New Weight Loss Drug Semaglutide Gives Women an Advantage Over Men

Research shows that men lose more weight than women when they diet, but semaglutide – the active ingredient in type 2 diabetes drug Ozempic and Wegovy – Designed for weight loss – gives women an advantage over men in losing weight.

Why do men lose more weight when dieting?

• They are stronger and have more muscle, which helps burn calories.
• They have a higher basal metabolism rate, which means they burn more calories while sitting and even while sleeping.
• Testosterone in men helps to lose weight.

But the good news is that women seem to do better than men when given weight-loss drugs such as “Ozambik” and “Wegovi”. According to new data, women lose a higher percentage of body weight than men.

Medicines such as sigmaltoids essentially mimic the action of the hormone GLP-1, which is released in the intestines in response to food intake, prompting the body to produce more insulin, which lowers blood sugar levels. For this reason, this drug was developed for people who already had type 2 diabetes.

But these drugs also affect the brain, suppressing appetite. People who have tried it say, “One of the biggest changes they have noticed is that they stop wanting to eat, and the result is significant weight loss.”

One of the first large studies to look at Sigmaltoid found that men and women who took the drug lost about 15.3 kilograms over 66 weeks.

What was also remarkable was that the women in the experiment lost a higher proportion of their starting weight than the men, around 18% versus 13%, according to a re-analysis of the data conducted by the researcher at the University of Sydney School of Medicine and Health. Alyssa Susanto.

Dr. Susanto presented her findings at the International Conference on Obesity in Melbourne, and she did not specify the reason for this difference between men and women, but it seems that the reason for this is that these new drugs act strongly on the brain and reduce appetite, and research indicates that women’s appetite is stronger than Men.

Dr. Susanto suggested that studying the differences between males and females in weight loss could lead to better and more personalized treatments.

The difference between the real estate “Ozambique” and “Wegovi”

Ozambik is approved as a treatment for people with type 2 diabetes, and Wiggoi is approved as a weight loss treatment for people who are obese or have health problems related to being overweight.

There is a difference in doses between the two drugs, depending on the case.

Dosage of “Ozambik” and how it is given

• Ozambik is given as an injection under the skin once a week, at any time of the day, with or without food. Use the injection on the same day each week.
• Starting with Ozambik is at a starting dose of 0.25 mg once a week for 4 weeks. This helps give your body a chance to get used to the medication.
• In the fifth week, the healthcare provider increases the dose to 0.5 mg once per week. This is according to the official website of the property.
• A person’s needs may change with a diabetic condition, which is why Osambik is available in 1 mg or 2 mg doses for additional glucose control.
• The maximum dose of “Ozambik” is 2 mg once a week.

Dosage of Wigovi and how it is administered

• Wigovy is given as an injection under the skin once a week, at any time of the day, with or without food. Use the injection on the same day each week.
• The person starts taking Waghofi at a dose of 0.25 mg per week in the first month According to the official website of the drug.
• In the second month the weekly dose can be increased to 0.5 mg.
• In the third month the weekly dose can be increased to 1 mg.
• In the fourth month, the weekly dose can be increased to 1.7 mg.
• From the fifth month onwards you can increase the weekly dose to the full dose of 2.4 mg.